Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Laser vs Clobetasol for Lichen Sclerosus
NCT05010421Phase 3Completed
- Sponsor
- Ruhr University Bochum
- Start
- Nov 2021
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in lichen sclerosus (LS) (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Vulvar burning, itching, and pain at 12 weeks. Started Nov 2021; status: completed.
02
Conditions
lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT05010421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010421.